
Excel Venture Management is a Boston-based venture capital firm that builds companies applying transformative life science technologies to solve problems in healthcare and beyond. The portfolio is balanced across healthcare IT and services, diagnostics, medical devices, and life science platforms.
43% of their portfolio is in Healthcare. Average disclosed round size is $17.0M (across 26 rounds with reported amounts).
Portfolio
21
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
28 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| OOgnomy Sleep | Series A | $20M | Aug 2024 |
| Series A | $10M | Jan 2019 | |
| Series B | $18M | Nov 2016 | |
| NN-of-One | Series B | $7M | Jul 2016 |
| Seed | $29.5M | Mar 2016 | |
| Series B | $22M | Dec 2015 | |
| Series B | $8M | Aug 2015 | |
| NNanoMR | Series B | $13M | Jan 2015 |
| Series E | $48M | Nov 2014 | |
| Growth | — | Sep 2014 | |
| Series B | $8M | Jan 2014 | |
| SShapeUP | Unknown | $7.5M | Nov 2013 |
| Series A | $12M | Jan 2013 | |
| Series C | $28M | Sep 2012 | |
| Series C | $28M | Jan 2012 | |
| AActivate Networks | Series B | $10M | Jan 2012 |
| Unknown | $13M | Sep 2011 | |
| Series B | $18.4M | Aug 2011 | |
| NNanoMR | Unknown | $13M | Jul 2011 |
| Series C | $8.4M | Mar 2010 | |
| MMedVentive | Series C | $10M | Aug 2009 |
| Series B | $17M | — | |
| IIlluminOss Medical | Series C | $28M | — |
| Series B | $15M | — | |
| TTetraphase Pharmaceuticals | Series C | $45M | — |
Page 1 of 2
Top Co-Investors
SR One5 shared
Launchpad Capital4 shared
Safeguard Scientifics, Inc.3 shared
New Leaf Venture Partners3 shared
Pappas Capital3 shared
TCA Venture Group2 shared
Broadview Ventures2 shared
Alexandria Venture Investments2 shared
B372 shared
Roche Venture Fund2 shared
AJU IB Investment2 shared
Apple Tree Partners2 shared
EQT Life Sciences2 shared
Tekla Capital Management2 shared
Enterprise Ireland2 shared
Frontline Ventures2 shared
Keiretsu2 shared
HLM Investment Partners2 shared
Windham Capital Partners1 shared
Last updated: 20 October 2026